Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 32

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Nov 16, 2023; 11(32): 7911-7919
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7911

Full Size Figure Download Figure

Figure 5 Timeline of Case 2’s clinical management and outcome. SDSC: SMARCB1-deficient sinonasal carcinomas.

Citation: Zhang L, Gao AX, He YL, Xu MJ, Lu HJ. Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports. World J Clin Cases 2023; 11(32): 7911-7919
URL: https://www.wjgnet.com/2307-8960/full/v11/i32/7911.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i32.7911

Zhang L, Gao AX, He YL, Xu MJ, Lu HJ. Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports. World J Clin Cases 2023; 11(32): 7911-7919 [PMID: 38073679 DOI: 10.12998/wjcc.v11.i32.7911]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.